
Lumpectomy vs Mastectomy: A Clear Guide to Your Choice
Lumpectomy vs mastectomy: for Stage I-II, survival rates are equal. Here are the 5 factors surgeons weigh before deciding.
Sameer Patel is the founder and editor of My Medicine Advisor. He is not a doctor or medical professional — before starting this site he worked in banking, and he now researches and edits health information full-time.
He started My Medicine Advisor to make clear, well-sourced health information freely available to anyone. Every article is researched from recognised authorities such as the WHO, CDC, NIH, and NICE, drafted with the help of AI tools, and edited by hand, with sources linked so readers can check them. The calculators on the site use established, published formulas, each one named so you can look it up yourself.
My Medicine Advisor is currently a one-person operation with no clinical review panel, and the site is open about that. If you're a qualified clinician or researcher interested in reviewing content, Sameer would genuinely like to hear from you via the contact page.

Lumpectomy vs mastectomy: for Stage I-II, survival rates are equal. Here are the 5 factors surgeons weigh before deciding.

DCIS breast cancer: 99% survival rate when treated, but grade 3 with comedo necrosis changes the surgical decision. A gynecologic oncologist explains.

Metastatic breast cancer treatment in 2026 depends on receptor status — which can change between your original tumor and the metastatic site.

Inflammatory breast cancer is Stage IIIB at every diagnosis per NCCN 2026 — it invades lymphatic vessels in the breast skin, never forming a lump.

HER2-positive breast cancer entered a new treatment era in 2026 after Enhertu reached 92.4% IDFS in DESTINY-Breast05 patients.

Triple-negative breast cancer: Stage I carries ~91% 5-year survival, but Stage IV drops to 12%. A gynecologic oncologist explains what pCR changes.

Breast cancer mammograms: ACS, USPSTF, and ACR now align on age 40 — but BRCA carriers start a decade earlier. Know your protocol.

Breast cancer risk: BRCA1 mutation raises lifetime risk to 72%. Each daily drink adds 10% more — and a 20% Tyrer-Cuzick score changes your care plan.

Breast cancer types determine which drugs you get. TNBC needs pembrolizumab; HER2+ needs trastuzumab. Know your type before your first appointment.

Stage IV breast cancer survival: 31% in 2026 data. A board-certified gynecologic oncologist explains what each stage and subtype means for your prognosis.